Daehan New Pharm Co. Ltd Net Asset Quality Index
Daehan New Pharm Co. Ltd net asset quality index. Daehan New Pharm Co. Ltd (054670) has a Net Asset Quality Index of 51.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩251.53 Billion minus total liabilities of ₩122.10 Billion yields net assets of ₩129.44 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 054670 total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Daehan New Pharm Co. Ltd (2014–2024)
Net asset quality index of Daehan New Pharm Co. Ltd from 2014 to 2024. This chart shows how Daehan New Pharm Co. Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 51.5%, representing net assets of ₩129.44 Billion against total assets of ₩251.53 Billion KRW. Check 054670 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Daehan New Pharm Co. Ltd Net Asset Quality Index by Year (2014–2024)
Daehan New Pharm Co. Ltd net asset quality index by year from 2014 to 2024. The table below presents the year-by-year Net Asset Quality Index for Daehan New Pharm Co. Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 054670 market cap overview.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 56.7% | ₩125.44 Billion | ₩221.29 Billion | ₩95.85 Billion | ▼ -5.1 pp |
| 2023 | 61.8% | ₩109.36 Billion | ₩176.93 Billion | ₩67.57 Billion | ▲ +1.0 pp |
| 2022 | 60.8% | ₩102.96 Billion | ₩169.36 Billion | ₩66.40 Billion | ▲ +8.5 pp |
| 2021 | 52.3% | ₩82.47 Billion | ₩157.64 Billion | ₩75.18 Billion | ▲ +9.4 pp |
| 2020 | 42.9% | ₩57.13 Billion | ₩133.08 Billion | ₩75.95 Billion | ▼ -4.8 pp |
| 2019 | 47.7% | ₩61.07 Billion | ₩127.91 Billion | ₩66.84 Billion | ▲ +8.1 pp |
| 2018 | 39.6% | ₩43.08 Billion | ₩108.74 Billion | ₩65.66 Billion | ▼ -2.8 pp |
| 2017 | 42.5% | ₩51.72 Billion | ₩121.82 Billion | ₩70.09 Billion | ▼ -12.0 pp |
| 2016 | 54.5% | ₩71.20 Billion | ₩130.72 Billion | ₩59.52 Billion | ▼ -3.7 pp |
| 2015 | 58.2% | ₩77.20 Billion | ₩132.63 Billion | ₩55.43 Billion | ▲ +1.6 pp |
| 2014 | 56.6% | ₩73.89 Billion | ₩130.47 Billion | ₩56.58 Billion | — |